Morepen Laboratories secures FDA approval for Fexofinadine (Allegra)
Morepen Laboratories Limited has secured approval from the US Food and Drug Administration (FDA) for its anti-allergy drug Fexofinadine Hydrochloride, which it expects to begin approval in the fourth quarter of 2022. The anti-allergy drug, which is sold in India under the brand names such as Allegra and others, was developed by France-based Sanofi Aventis. […]